DEL MAR PHARMACEUTICALS (BC) LTD. GRANTED PATENT FOR METHODS FOR ANALYSIS AND RESOLUTION OF PREPARATIONS OF DIANHYDROGALACTITOL AND DERIVATIVES OR ANALOGS THEREOF.

Kintara Therapeutics (Formerly known as DelMar Pharmaceuticals) functions as a clinical and commercial-stage drug manufacturing enterprise that specifically targets the treatment of cancer. The Company concentrates on recognizing clinical and commercial-stage elements and establishing a scientific purpose for the formulation in fresh orphan drug indications. Kintara Therapeutics offers its services to customers all over the world.

Delmar Pharmaceuticals (BC) LTD. filed a patent application numbered 201817023257 that is titled METHODS FOR ANALYSIS AND RESOLUTION OF PREPARATIONS OF DIANHYDROGALACTITOL AND DERIVATIVES OR ANALOGS THEREOF. The patent has been filed in the field of Chemicals. This Patent Application has been granted as Patent Number 352911. This invention relates to an analytical method for analyzing the presence and quantity of impurities present in a preparation of dianhydrogalactitol comprising various steps.

During the patent examination, the Patent Examiner raised objections under Section 3(d) of the Patents Act, 1970 stating that the analytical method for analyzing the presence and quantity of impurities present in a preparation of dianhydrogalactitol as defined in the claims is a mere use of a known method which does not result in enhancement of efficacy of a known method (for improved analytical methods for dianhydrogalactitol and derivatives or analogs thereof).

As a response, the Applicant submitted that the claimed method provides an improvement over the analytical method of D1, for instance, a comparison of chromatographic results for DAG and its impurities. Hence, the subject matter of the claims should be held patentable.

Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.

Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).

Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.